Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 12.31
+0.08 (0.65%)
Aug 15, 2025, 4:12 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 615.62 million as of August 15, 2025. Its market cap has decreased by -10.07% in one year.
Market Cap
615.62M
Enterprise Value
418.11M
Revenue
91.02M
Ranking
n/a
PE Ratio
16.00
Stock Price
12.31
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 615.62M, an increase of 11,680.70%. That is a compound annual growth rate of 21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 615.62M | 2.20% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | 1.10B | -21.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.79B |
| Pro Medicus | 32.98B |
| Cochlear | 20.01B |
| Sonic Healthcare | 14.07B |
| Ramsay Health Care | 9.02B |
| Telix Pharmaceuticals | 5.76B |
| Ansell | 4.58B |
| Mesoblast | 3.11B |